Bull
$42.91
Scenario price
$38.020
+0.498 (+1.31%)At close
Genpact Limited is an agentic and technology solutions company. The Company's segments include Financial Services, Consumer and Healthcare, and High Tech and Manufacturing. The Financial Services segment covers the technology solutions and business services provided to clients in the banking, capital markets and insurance sectors. Its banking and capital markets clients include retail, investment and commercial banks, equipment and lease financing providers. The Consumer and Healthcare segment covers the technology solutions and business services provided to clients in the consumer goods, retail, life sciences and healthcare sectors. Its consumer goods and retail clients include companies in the food and beverage, household goods, consumer health and beauty and apparel industries. The High Tech and Manufacturing segment covers the technology solutions and business services we provide to clients in the high-tech hardware, high-tech software and manufacturing sectors.
Genpact Ltd is a good buy right now due to its strong Q2 earnings report showing a non-GAAP EPS of $1.00, which beat expectations by $0.03, and a revenue of $1.34 billion, reflecting a 7.2% year-over-year growth. The current price of $38.02 is below the average analyst price target of $42.5, suggesting a significant upside potential of approximately 12%. However, the stock has seen a decline of 17.19% year-to-date, indicating some market volatility that investors should consider.
TD Cowen
$43
2026-08-07
TD Cowen
2026-08-07
Price Target
$43
Needham
$45
2026-08-07
Needham
2026-08-07
Price Target
$45
BMO Capital
$40
2026-08-07
BMO Capital
2026-08-07
Price Target
$40
Susquehanna
$37
2026-08-07
Susquehanna
2026-08-07
Price Target
$37
TD Cowen
$42
2026-07-09
TD Cowen
2026-07-09
Price Target
$42
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Genpact Named One of TIME's Most Sustainable Companies for Second Year

Genpact Q2 Earnings Analysis Compared to Peers

Genpact Recognized as Leader in Financial Crime Compliance by HFS

Genpact Q2 Earnings Exceed Expectations

TaskUs Shares Surge 5.1% Amid Strong AI Demand
Genpact Limited is an agentic and technology solutions company. The Company's segments include Financial Services, Consumer and Healthcare, and High Tech and Manufacturing. The Financial Services segment covers the technology solutions and business services provided to clients in the banking, capital markets and insurance sectors. Its banking and capital markets clients include retail, investment and commercial banks, equipment and lease financing providers. The Consumer and Healthcare segment covers the technology solutions and business services provided to clients in the consumer goods, retail, life sciences and healthcare sectors. Its consumer goods and retail clients include companies in the food and beverage, household goods, consumer health and beauty and apparel industries. The High Tech and Manufacturing segment covers the technology solutions and business services we provide to clients in the high-tech hardware, high-tech software and manufacturing sectors. It operates in the Industrials sector (SERVICES-MANAGEMENT CONSULTING SERVICES industry).
Genpact Ltd is a good buy right now due to its strong Q2 earnings report showing a non-GAAP EPS of $1.00, which beat expectations by $0.03, and a revenue of $1.34 billion, reflecting a 7.2% year-over-year growth. The current price of $38.02 is below the average analyst price target of $42.5, suggesting a significant upside potential of approximately 12%. However, the stock has seen a decline of 17.19% year-to-date, indicating some market volatility that investors should consider.
13 analysts cover G: 6 rate it Buy, 5 Hold and 2 Sell. The average price target is 50.57.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。